Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tesofensine : Originally developed for neurodegenerative disorders, this triple monoamine reuptake inhibitor demonstrated substantial appetite suppression and weight loss in clinical trials
They bind to specific receptors on cell surfaces and trigger targeted biological responses
Mackus, M
What NOT to expect in the first 3 nights: Sedation (DSIP is not a sedative a drugged or groggy feeling is a signal to check the dose) Complete resolution of chronic insomnia (sleep architecture remodeling takes longer) Stress or cortisol changes (HPA axis modulation requires sustained dosing) Administration timing: Community protocols describe subcutaneous DSIP 30-60 minutes before the intended sleep time
TB 500: 25 mg weekly, often used systemically
US$ 27.20
US$ 24.31
US$ 26.76
US$ 27.26
US$ 28.82
